Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enterococcus faecium L6 + Lactobacillus plantarum L10
- Development stage
- Preclinical
- Lead developer
- Northeast Agricultural University
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
*Enterococcus faecium* L6 + *Lactobacillus plantarum* L10 is a combination live biotherapeutic product (LBP) consisting of two specific probiotic bacterial strains. It is primarily investigated for use in the poultry industry as a sustainable alternative to antibiotic growth promoters. The therapy aims to improve growth performance and carcass yield in broilers while providing protection against Enterohemorrhagic *Escherichia coli* (EHEC) O157:H7 infections. Its mechanism of action involves the beneficial modulation of the cecal microbiota, enhancement of the intestinal mucosal barrier function, and stimulation of the host's immune and antioxidant systems. By promoting a healthy gut environment and strengthening host defenses, this combination reduces pathogen colonization and supports overall avian health.
- Other names
- Enterococcus faecium L6 and Lactobacillus plantarum L10 combinationL6+L10 probiotic
Beyond the preview
Go deeper on Enterococcus faecium L6 + Lactobacillus plantarum L10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enterococcus faecium L6 + Lactobacillus plantarum L10.